The next round of bellwether trials in the Pinnacle multidistrict litigation will move forward despite a petition by the defendants Johnson & Johnson and DePuy Orthopedics to prevent them. The…

DePuy’s parent company, Johnson & Johnson, has announced that it will enter into a $2.475 billion DePuy hip settlement agreement with plaintiffs in MDL 2197. The DePuy hip settlement covers…

Article by guest commentator K.J. Bard

In recent news, the DePuy Orthopaedics division of Johnson & Johnson will be abandoning the manufacture and marketing of its metal-on-metal (MoM)…

 In the past, DePuy vigorously supported the continued use of metal-on-metal hip implants, even when mounting evidence through the registries and surgeons’ experiences showed that these types of…

The most recent Chicago DePuy ASR trial has ended with a favorable verdict for the defense. In contrast with the recent $8.3 million California verdict for plaintiff Loren Kransky in California…

"DePuy Orthopaedics Hips. Real Life Tested"

Those words still appear on a website maintained by the company (play the videos at the…

For a long time, the four manufacturers of hip and joint replacements that controlled 75% of the market were laughing all the way to the bank.  These four companies – Stryker, Biomet, Du Puy and…

In a recent news article, Gregory Demske, assistant inspector general for the U.S. Department of Health and Human Services, reported that the four largest manufacturers of hip replacements – all…

LP attorney Ben Gordon quoted on the impact of the verdict for the plaintiff.

http://blogs.…

A California Jury returned an $8.3 million verdict against Johnson & Johnson and DePuy in the first trial regarding a plaintiff who was implanted with the recalled DePuy ASR hip implant.  Over…